Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31development of software2024-04-01false1511truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 10655443 2024-04-01 2025-03-31 10655443 2023-04-01 2024-03-31 10655443 2025-03-31 10655443 2024-03-31 10655443 c:Director2 2024-04-01 2025-03-31 10655443 d:FurnitureFittings 2024-04-01 2025-03-31 10655443 d:FurnitureFittings 2025-03-31 10655443 d:FurnitureFittings 2024-03-31 10655443 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 10655443 d:OfficeEquipment 2024-04-01 2025-03-31 10655443 d:OfficeEquipment 2025-03-31 10655443 d:OfficeEquipment 2024-03-31 10655443 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 10655443 d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 10655443 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 10655443 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 10655443 d:CurrentFinancialInstruments 2025-03-31 10655443 d:CurrentFinancialInstruments 2024-03-31 10655443 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 10655443 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 10655443 d:ShareCapital 2025-03-31 10655443 d:ShareCapital 2024-03-31 10655443 d:SharePremium 2025-03-31 10655443 d:SharePremium 2024-03-31 10655443 d:RetainedEarningsAccumulatedLosses 2025-03-31 10655443 d:RetainedEarningsAccumulatedLosses 2024-03-31 10655443 d:TaxLossesCarry-forwardsDeferredTax 2025-03-31 10655443 d:TaxLossesCarry-forwardsDeferredTax 2024-03-31 10655443 c:OrdinaryShareClass1 2024-04-01 2025-03-31 10655443 c:OrdinaryShareClass1 2025-03-31 10655443 c:OrdinaryShareClass1 2024-03-31 10655443 c:FRS102 2024-04-01 2025-03-31 10655443 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10655443 c:FullAccounts 2024-04-01 2025-03-31 10655443 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10655443 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:InternallyGeneratedIntangibleAssets 2024-04-01 2025-03-31 10655443 2 2024-04-01 2025-03-31 10655443 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:OwnedIntangibleAssets 2024-04-01 2025-03-31 10655443 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 10655443









HEALTHROTA LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

 
HEALTHROTA LIMITED
REGISTERED NUMBER: 10655443

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 4 
852,716
819,709

Tangible assets
 5 
15,650
21,226

  
868,366
840,935

Current assets
  

Debtors: amounts falling due within one year
 6 
278,939
390,566

Cash at bank and in hand
 7 
227,334
62,777

  
506,273
453,343

Creditors: amounts falling due within one year
 8 
(496,117)
(409,889)

Net current assets
  
 
 
10,156
 
 
43,454

  

Net assets
  
878,522
884,389


Capital and reserves
  

Called up share capital 
 10 
1,604
1,604

Share premium account
  
25,424
25,424

Profit and loss account
  
851,494
857,361

  
878,522
884,389


Page 1

 
HEALTHROTA LIMITED
REGISTERED NUMBER: 10655443
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 5 December 2025.




................................................
J D R Barry
Director

The notes on pages 3 to 10 form part of these financial statements.

Page 2

 
HEALTHROTA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Healthrota Limited ("the Company") is a private company limited by shares, incorporated in England and Wales. Its registered office is 41 Dartmouth Park Road, London, NW5 1SU. The principal activity of the Company is the development of software.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Page 3

 
HEALTHROTA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.5

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.6

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 4

 
HEALTHROTA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.8

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.9

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.10

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 5

 
HEALTHROTA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.11

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
25%
straight-line
Office equipment
-
25%
straight-line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.12

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.13

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.14

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 15 (2024 - 11).

Page 6

 
HEALTHROTA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


Intangible assets




Development expenditure

£



Cost


At 1 April 2024
930,777


Additions - internal
126,640



At 31 March 2025

1,057,417



Amortisation


At 1 April 2024
111,068


Charge for the year on owned assets
93,633



At 31 March 2025

204,701



Net book value



At 31 March 2025
852,716



At 31 March 2024
819,709



Page 7

 
HEALTHROTA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.


Tangible fixed assets





Fixtures and fittings
Office equipment
Total

£
£
£



Cost or valuation


At 1 April 2024
1,778
37,779
39,557


Additions
-
4,608
4,608



At 31 March 2025

1,778
42,387
44,165



Depreciation


At 1 April 2024
1,370
16,961
18,331


Charge for the year on owned assets
408
9,776
10,184



At 31 March 2025

1,778
26,737
28,515



Net book value



At 31 March 2025
-
15,650
15,650



At 31 March 2024
408
20,818
21,226


6.


Debtors

2025
2024
£
£


Trade debtors
179,656
299,751

Other debtors
44,151
12,688

Prepayments and accrued income
13,018
12,916

Deferred taxation
42,114
65,211

278,939
390,566



7.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
227,334
62,777


Page 8

 
HEALTHROTA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

8.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
28,487
1,971

Other taxation and social security
55,314
93,842

Other creditors
3,871
4,586

Accruals and deferred income
408,445
309,490

496,117
409,889



9.


Deferred taxation




2025


£






At beginning of year
65,211


Charged to profit or loss
(23,097)



At end of year
42,114

The deferred tax asset is made up as follows:

2025
2024
£
£


Tax losses carried forward
42,114
65,211

Page 9

 
HEALTHROTA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

10.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



16,040 (2024 - 16,040) Ordinary shares of £0.10 each
1,604
1,604



11.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £19,845 (2024 - £14,832). At the balance sheet date, the Company had contributions totalling £3,871 (2024 - £3,848) due to the fund.

 
Page 10